Accelr8 Technology Corporation (www.accelr8.com) is a developer of innovative materials and instrumentation for advanced applications in medical instrumentation, basic research, drug discovery, and bio-detection. Accelr8 is developing rapid clinical pathogen platforms, the BACcel(TM)-1.0 and the BACcelr8r(TM), based on its innovative surface coatings, assay processing, and detection technologies. In addition, Accelr8 licenses certain of its proprietary technology for use in applications outside of Accelr8's own products.

Contact Information

7000 North Broadway
Building 3-307
Denver, CO 80221

tel: 303-863-8088
fax: 303-863-1218


Investor Relations



Exchange: AMEX
Industry: Scientific & Technical Instruments
Market Cap: $47.3M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.